Rockwell Medical, Inc.
RMTI
$0.80
-$0.04-4.99%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 69.26M | 75.58M | 87.97M | 97.73M | 101.49M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 69.26M | 75.58M | 87.97M | 97.73M | 101.49M |
| Cost of Revenue | 57.56M | 64.13M | 72.55M | 80.27M | 84.01M |
| Gross Profit | 11.70M | 11.45M | 15.42M | 17.46M | 17.48M |
| SG&A Expenses | 16.39M | 16.26M | 16.71M | 16.89M | 16.86M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.95M | 80.39M | 89.26M | 97.16M | 100.88M |
| Operating Income | -4.69M | -4.81M | -1.29M | 572.00K | 608.00K |
| Income Before Tax | -5.31M | -5.52M | -2.10M | -264.00K | -480.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.31 | -5.52 | -2.10 | -0.26 | -0.48 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.31M | -5.52M | -2.10M | -264.00K | -480.00K |
| EBIT | -4.69M | -4.81M | -1.29M | 572.00K | 608.00K |
| EBITDA | -2.50M | -2.62M | 896.00K | 2.75M | 2.79M |
| EPS Basic | -0.16 | -0.17 | -0.08 | -0.02 | -0.04 |
| Normalized Basic EPS | -0.10 | -0.10 | -0.04 | 0.00 | -0.01 |
| EPS Diluted | -0.16 | -0.18 | -0.09 | -0.03 | -0.04 |
| Normalized Diluted EPS | -0.10 | -0.10 | -0.04 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 143.85M | 137.32M | 132.85M | 128.99M | 124.21M |
| Average Diluted Shares Outstanding | 143.85M | 137.32M | 133.72M | 131.44M | 126.66M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |